Skip to content

Study · In vitro (cells) · 1998

2 results

Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization.

Boado RJ

Neuroscience letters1 Oct 1998Cited by 14 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In cultured brain endothelial cells, Cerebrolysin reduced GLUT1 mRNA fractional turnover from 72.4 to 4.0%/h compared with control cells.

    In plain wordsIn cells from brain blood vessels, Cerebrolysin reduced GLUT1 message turnover compared with control cells.

    Outcome
    DecreaseGLUT1 mRNA fractional turnover rate
    Study

    n: not reported in source

    Brain endothelial cultured cells transfected with human GLUT1 transcript
    Comparator
    Control cells
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Fractional turnover rate
    72.4 %/h
    Control
    Fractional turnover rate
    4 %/h
    Cerebrolysin

    Source sentences

    Summary
    On the contrary, the decay of the hGLUT1 mRNA was stabilized in CI-treated cells resulting in a marked reduction in the fractional turnover rate (72.4 and 4.0%/h, control and CI, respectively).
    2 context sentences
    Summary · context
    The present investigation studied the effect of the brain-derived peptide preparation Cerebrolysin (CI, EBEWE, Austria) on the turnover rate and gene expression of the blood-brain barrier (BBB) GLUT1 glucose transporter mRNA.
    Summary · context
    Studies were performed in brain endothelial cultured cells transfected with the human (h) GLUT1 transcript.
  2. 02LabIn vitro (cells)Mechanism

    In cultured brain endothelial cells, Cerebrolysin significantly increased immunoreactive GLUT1 protein levels.

    In plain wordsIn cells from brain blood vessels, Cerebrolysin increased GLUT1 protein levels compared with control cells.

    Outcome
    IncreaseImmunoreactive GLUT1 protein
    Study

    n: not reported in source

    Brain endothelial cultured cells transfected with human GLUT1 transcript
    Comparator
    Control cells
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In parallel experiments, CI induced a significant increase in the levels of immunoreactive GLUT1 protein measured by enzyme-linked immunosorbent assay (ELISA).
    2 context sentences
    Summary · context
    The present investigation studied the effect of the brain-derived peptide preparation Cerebrolysin (CI, EBEWE, Austria) on the turnover rate and gene expression of the blood-brain barrier (BBB) GLUT1 glucose transporter mRNA.
    Summary · context
    Studies were performed in brain endothelial cultured cells transfected with the human (h) GLUT1 transcript.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.